Diabetes Devices Market Report

Diabetes Devices Market Analysis By Device Type (Self-monitoring & Diagnostic Devices (Lancets, Analog Glucose Meter, Continuous Glucose Monitor & Test Strips)), Delivery Type (Syringes, Pumps, Pens, Injectors) And Segment Forecasts To 2024

  • Published Date: Jun, 2018
  • Base Year for Estimate: 2016
  • Report ID: 978-1-68038-873-2
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2015
  • Number of Pages: 67

Industry Insights

The global diabetes devices market size was valued at USD 20.7 billion in 2016 and is expected to develop at a CAGR of 7.0% over the forecast period. Demand for diabetes devices is increasing due to growth in target population base. Growing cases of diabetes caused due to obesity, unhealthy lifestyles and eating habits, age, and other factors are leading factors driving market growth. Obesity is believed to be one of the foremost factors leading to the development of diabetes in individuals. 

U.S. diabetes devices market

According to WHO, in 2014, over 1.9 billion people were identified to be overweight, of which, around 600 million people were obese. Diabetes devices are used for blood diagnostics and monitoring as well as for delivering insulin. Major companies in the market are focusing on development of minimally invasive and user-friendly devices to fulfill growing demand.

Rising prevalence of diabetes owing to sedentary lifestyle is a key factor for market growth. On the other hand, stringent regulatory guidelines are limiting the scope of the market. In addition, development of non-invasive insulin delivery methods, such as oral administration and inhalation, are a potential threat to the delivery device segment.

Nevertheless, increasing funding from private and government agencies, along with rising number of research and development activities for diabetes control and treatment solutions is slated to offer a host of opportunities for market players, thereby contributing toward market expansion.

Product Type Insights

Based on product, the market is segmented into monitoring and diagnostic devices and insulin delivery devices. Monitoring and diagnostic devices are sub-segmented into analog glucose meter, continuous glucose monitoring, lancets, and test strips. Insulin delivery devices are further segmented into syringes, pens, pumps, and injectors.

Test strips captured the largest share in the monitoring and diagnostics device segment in 2015, while insulin pens accounted for the dominant share among insulin delivery devices. Rapid adoption of these user-friendly, quick, and accurate devices by patients for homecare use is estimated to boost market demand during the forecast period. Increasing awareness regarding diabetes, along with availability of a wide range of devices with quick and accurate results, is anticipated to fuel the segments at a lucrative rate during the forecast period.

Global diabetes devices market

Insulin pens formed the largest segment in terms of revenue. Increasing usage by diabetes patients, technological advancements, and ability of these devices to deliver accurate dosage are factors contributing toward segment growth. Rising focus of manufacturers on promoting product innovation and advancement is another major factor driving the segment. Factors such as high adoption rate, user-friendly product design, and soaring popularity amongst consumers also contributed toward segment expansion.

Regional Insights

North America is the most developed market, followed by Europe. Advanced healthcare infrastructure and availability of technologically advanced products are key factors responsible for this market. U.S., in particular, is the largest market for diabetes devices across the world on account of wide adoption of these devices in the country.

Asia Pacific is estimated to exhibit the highest growth rate over the next few years. This growth is attributed to availability of several untapped opportunities, along with rising geriatric population base in this region. The adoption rate of insulin devices is high in several Asian countries, such as India and China.

Factors such as growing awareness regarding diabetes care and developing healthcare landscape are leading factors responsible for a higher adoption rate of these devices. Additionally, growing healthcare spending in these economies has resulted in a rise in adoption of technologically advanced products, thereby boosting regional market growth.

Diabetes Devices Market Share Insights

Some of the key players in the market are Medtronic PLC, Sanofi S.A., Bayer Healthcare AG, Becton, Dickinson and Company, Novo Nordisk A/S, Abbott Laboratories, F. Hoffman-La Roche AG, and Johnson & Johnson.

Most of these key players have adopted various strategies such as new product launch, collaborations, and mergers and acquisitions to strengthen their industry position. For instance, in August 2016, Medtronic PLC announced the launch of MiniMed 630G system combined with SmartGuard technology in the U.S. market. This insulin pump has received approval for treatment of adults suffering from diabetes mellitus.

Report Scope



Base year for estimation


Actual estimates/Historical data

2014 - 2015

Forecast period

2017 - 2024

Market representation

Revenue in USD Million & CAGR from 2017 to 2024

Regional scope

North America, Europe, Asia Pacific, Latin America & MEA

Country scope

U.S., Canada, U.K., Germany, China, India, Brazil, Mexico, & South Africa

Report coverage

Revenue, company share, competitive landscape, growth factors, trends

15% free customization scope (equivalent to 5 analysts working days)

If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on latest industry trends and opportunities in each of the sub-segments from 2014 to 2024. For the purpose of this study, Grand View Research has segmented the global diabetes devices market report on the basis of product and region:

  • Product Type Outlook (Revenue, USD Million, 2014 - 2024)

    • Monitoring and Diagnostic Devices

      • Lancets

      • Analog Glucose Monitor

      • Continuous Glucose Monitor

      • Test Strips

    • Insulin Delivery Devices

      • Syringe

      • Pens

      • Pumps

      • Injectors

  • Regional Outlook (Revenue, USD Million, 2014 - 2024)

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

    • Asia Pacific

      • China

      • India

    • Latin America

      • Mexico

      • Brazil

    • MEA

      • South Africa

Key questions answered by the report
Request for Customization

Pricing & Purchase Options

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • grand view research PCI DSS complaint grand view research paypal verified